Open Access

Regulatory role of microRNA‑320 during off‑pump coronary artery bypass grafting with dexmedetomidine adjunct anesthesia

  • Authors:
    • Yan Gao
    • Xiaolong Zhu
    • Huidan Yu
    • Wenlong Wang
    • Yeming Wang
    • Fulong Li
    • Jinliang Teng
  • View Affiliations

  • Published online on: August 23, 2021     https://doi.org/10.3892/etm.2021.10635
  • Article Number: 1201
  • Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study investigated the effects of dexmedetomidine on the expression level of microRNA‑320 (miR‑320) and neuroglobin (NGB) in patients undergoing off‑pump coronary artery bypass grafting (OPCABG). A total of 40 patients undergoing OPCABG were recruited and randomly divided into the dexmedetomidine and normal saline groups (treated before anesthesia), respectively. The NGB levels in the blood samples before and after surgery were analyzed and compared. The CATH.a cells were cultured and induced with dexmedetomidine, and the NGB expression level was detected. CATH.a cells were treated with NGB and lipopolysaccharide (LPS), and the cell survival rate was determined. The miR‑320 expression levels in the blood samples and dexmedetomidine‑induced cells were detected. Dual‑luciferase reporter assay was performed. Compared with control subjects, patients in the dexmedetomidine group had higher NGB levels in the blood. In the CATH.a cells, the dexmedetomidine treatment upregulated the NGB levels. Moreover, upon pre‑incubation with NGB and LPS stimulation, dexmedetomidine elevated cell viability. Furthermore, miR‑320 expression levels were significantly downregulated in the blood of patients in the dexmedetomidine group, as well as in the dexmedetomidine‑induced cells. Dual‑luciferase reporter assay confirmed that miRNA‑320a directly targeted on NGB, and upregulated miRNA‑320a in CATH.a cells decreased cell proliferation activity. Pre‑administration of dexmedetomidine can decrease miR‑320 expression level in the blood of patients undergoing OPCABG, stimulating the high expression of NGB and increasing the proliferation activity of neuronal cells, which may decrease the postoperative cognitive impairment.
View Figures
View References

Related Articles

Journal Cover

November-2021
Volume 22 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gao Y, Zhu X, Yu H, Wang W, Wang Y, Li F and Teng J: Regulatory role of microRNA‑320 during off‑pump coronary artery bypass grafting with dexmedetomidine adjunct anesthesia. Exp Ther Med 22: 1201, 2021.
APA
Gao, Y., Zhu, X., Yu, H., Wang, W., Wang, Y., Li, F., & Teng, J. (2021). Regulatory role of microRNA‑320 during off‑pump coronary artery bypass grafting with dexmedetomidine adjunct anesthesia. Experimental and Therapeutic Medicine, 22, 1201. https://doi.org/10.3892/etm.2021.10635
MLA
Gao, Y., Zhu, X., Yu, H., Wang, W., Wang, Y., Li, F., Teng, J."Regulatory role of microRNA‑320 during off‑pump coronary artery bypass grafting with dexmedetomidine adjunct anesthesia". Experimental and Therapeutic Medicine 22.5 (2021): 1201.
Chicago
Gao, Y., Zhu, X., Yu, H., Wang, W., Wang, Y., Li, F., Teng, J."Regulatory role of microRNA‑320 during off‑pump coronary artery bypass grafting with dexmedetomidine adjunct anesthesia". Experimental and Therapeutic Medicine 22, no. 5 (2021): 1201. https://doi.org/10.3892/etm.2021.10635